Immunosuppressive mediations are essential to prevent graft rejection
and to optimize graft survival. However, because these medications suppress
the immune system, whose main function is to fight off infection and prevent
the development of cancer, transplant recipients are at elevated risk
for infection and certain cancers.
The exact mechanism by which immunosuppressive medications promote tumor
growth is currently being studied. However, several lines of evidence
suggest the duration, intensity and type of immunosuppressant may be related
to the development of skin cancer.
- Skin cancer (most common)
- Cervial cancer
- Liver cancer